Your Lab Results Are a Love Letter From Your Future Self

Yes. GLP-1 receptor agonists were originally developed for type 2 diabetes management, and the clinical evidence for glycemic improvement is extensive. In major trials, participants saw significant reductions in HbA1c levels, with many moving from pre-diabetic ranges back into normal ranges. GLP-1 therapy works by enhancing your body's natural insulin response and slowing glucose absorption. Your FormBlends physician will monitor your metabolic markers throughout treatment and coordinate with your primary care provider to track improvements in your bloodwork over time.

GLP-1 therapy has been shown to produce meaningful improvements across multiple cardiometabolic markers, not just body weight. In the SELECT trial published in the New England Journal of Medicine, semaglutide demonstrated a 20% reduction in major adverse cardiovascular events. Participants in clinical trials have also shown improvements in blood pressure, triglycerides, and inflammatory markers. While individual results vary, the systemic metabolic benefits of GLP-1 therapy extend well beyond the number on the scale. Your FormBlends physician will track all relevant markers as part of your personalized care plan.

Absolutely, and we encourage it. Your FormBlends physician will provide documentation of your treatment plan that you can share with your primary care provider. Many of our members find that their PCPs are supportive once they see the clinical evidence and the structured medical supervision we provide. In fact, some members were first recommended GLP-1 therapy by their own doctors but could not access it through insurance. FormBlends bridges that gap with affordable, physician-supervised access. We believe in collaborative care, your health team should be working together.

Pre-diabetes is actually one of the clinical scenarios where GLP-1 therapy shows some of its most compelling benefits. These medications were originally designed for glycemic management, and they have a strong safety profile in patients with metabolic concerns. Your FormBlends physician will review your complete health history, current medications, and recent lab work before prescribing. If you are taking metformin or other glucose-management medications, your physician will coordinate your treatment plan accordingly. Every protocol is individualized to your specific health situation.

We recommend that all FormBlends members get baseline bloodwork before starting therapy and follow-up labs at 90-day intervals. Key markers to track include HbA1c (blood sugar average), fasting glucose, blood pressure, triglycerides, LDL and HDL cholesterol, and inflammatory markers like C-reactive protein. Your FormBlends physician will help you understand what each number means and how your trends are improving. Many members bring their FormBlends progress reports to their primary care appointments, and their doctors are often impressed by the improvements.

Many FormBlends members are on existing medications when they begin GLP-1 therapy, and this is completely normal. Your prescribing physician will review all current medications during your consultation to ensure there are no contraindications. In many cases, as metabolic health improves with GLP-1 therapy, members work with their primary care providers to reduce dosages of blood pressure or cholesterol medications over time. We never recommend adjusting existing prescriptions without your PCP's involvement, your FormBlends care team and your primary care doctor work together.

This is a fair and important question. GLP-1 therapy is a medical tool that addresses the biological mechanisms driving weight gain and metabolic dysfunction. Think of it this way: if your blood sugar, blood pressure, and cholesterol are trending toward chronic disease, the alternative is often multiple lifetime medications to manage each condition separately, plus the long-term health consequences of uncontrolled metabolic syndrome. GLP-1 therapy addresses the root driver. Many members see improvements across all their metabolic markers simultaneously, and some are eventually able to reduce or discontinue other medications under their doctor's supervision.